NCT00073437View on ClinicalTrials.gov

A Study of Infliximab in Patients With Sarcoidosis

PHASE3CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

February 28, 2005

Conditions
Sarcoidosis
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY

NCT00073437 - A Study of Infliximab in Patients With Sarcoidosis | Biotech Hunter | Biotech Hunter